Search

everythinglearnresearchcommunity

for

Search:↓

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Skin and nail problems like hair loss, dry skin, and fungal infections are common in people with long-term Type 2 Diabetes and can be prevented with good blood sugar control and foot care.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

The man has a genetic skin condition called pachyonychia congenita.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

A 10-year-old boy's nail condition is mainly cosmetic and improves over time with treatment.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

A 12-year-old boy with twenty nail dystrophy, a condition affecting all nails, was treated conservatively due to its self-limiting nature and good prognosis.

The document concludes that scalp conditions have various causes and can present in many different ways.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

EGFR inhibitors can cause yellowish skin eruptions.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Elderly in South India commonly suffer from skin issues like wrinkles, dryness, and infections, needing better skin care education.

Skin problems are very common in people with end-stage kidney disease.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Chronic kidney disease can cause skin issues that need early recognition and combined treatment for better outcomes.

Darier-White disease causes skin and nail issues, starts around age 20, worsens until 40-50, and has poor treatment options.